Infokiri

Saatja: EVD Admin <[email protected]>

Saadetud: 22.10.2024 19:21

Adressaat: mateusz.markowicz <[email protected]>; stephan.aberle

<[email protected]>; tinne.lernout

<[email protected]>; Javiera Rebolledo

<[email protected]>; elica.panayotova

<[email protected]>; iva_trrifonova <[email protected]>;

mikov <[email protected]>; zvjezdana.lovric <[email protected]>;

iva.pem-novosel <[email protected]>; aaristodimou

<[email protected]>; Valentinos Silvestros

<[email protected]>; m.mendris <[email protected]>; mviolaris

<[email protected]>; Hana Orlíková <[email protected]>;

hana.zelena <[email protected]>; Lasse Skafte Vestergaard

<[email protected]>; pvb <[email protected]>; Juta Varjas <[email protected]>;

Maria Vikentjeva <[email protected]>; pamela.osterlund

<[email protected]>; Liina Voutilainen <[email protected]>;

Marie-Claire PATY <[email protected]>; Henriette

de Valk <[email protected]>; frankc

<[email protected]>; WilkingH <[email protected]>; Danai Pervanidou

<[email protected]>; molnar.zsuzsanna

<[email protected]>; <[email protected]>; Anna

Margrét Guðmundsdóttir - Landl <[email protected]>;

Kamilla Sigríður Jósefsdóttir - Landl <[email protected]>;

Paul.McKeown <[email protected]>; Patricia Garvey

<[email protected]>; aoife.colgan <[email protected]>; Riccardo

Flavia <[email protected]>; Federica Ferraro <[email protected]>;

Antra Bormane <[email protected]>; Visscher Carla

<[email protected]>; Walser-Domjan Esther <Esther.Walser-

[email protected]>; algirdas.griskevicius <[email protected]>;

Galina Zagrebnevienė <[email protected]>; milda.zygutiene

<[email protected]>; Melillo Tanya at Health Regulation

<[email protected]>; Borg Maria-Louise at Health Regulation <maria-

[email protected]>; Chantal Reusken <[email protected]>; Eelco

Franz <[email protected]>; Elisabeth Astrup <[email protected]>;

Johansen, Tone Kristin Bjordal <[email protected]>; Sadkowska-Todys

Małgorzata <[email protected]>; Carolina Isabel Bernardes Torres

<[email protected]>; Paula Vasconcelos

<[email protected]>; Anca Sirbu <[email protected]>;

jana.kerlik <[email protected]>; edita.staronova

<[email protected]>; maja.socan <[email protected]>; eva.grilc

<[email protected]>; Sierra Moros. María José <[email protected]>;

Paz Sánchez-Seco <[email protected]>; anette.richardson

<[email protected]>;

[email protected]

<[email protected]>

Koopia: NC_CCB_Austria <[email protected]>; sigrid.kiermayr

<[email protected]>; koen.blot

<[email protected]>; <[email protected]>; Zhivka Getsova

<[email protected]>; Iva Christova <[email protected]>; kcapak

<[email protected]>; bernard.kaic <[email protected]>; Elisavet

Constantinou <[email protected]>; <[email protected]>; Hana

Orlíková <[email protected]>; Kamilla Grønborg Laut <[email protected]>;

Stine Ulendorf Jacobsen <[email protected]>; Kärt Sõber

<[email protected]>; Julia Geller <[email protected]>;

TA Info <[email protected]>; Otto Helve <[email protected]>;

Savolainen-Kopra Carita <[email protected]>; Paula GARCIA-

LOBATO <[email protected]>; Anne-Catherine VISO

<[email protected]>; Lea Rathmachers

<[email protected]>; <[email protected]>; Rexroth, Ute <[email protected]>;

AnderHeidenMa <[email protected]>; Theodora Kalomama

<[email protected]>; Dimitrios Paraskevis

<[email protected]>; Christakis Chatzichristodoulou

<[email protected]>; Agnes Danielisz

<[email protected]>; <[email protected]>;

<[email protected]>; Guðrún Aspelund - Landl

<[email protected]>; lois.oconnor <[email protected]>;

Aine Grace <[email protected]>; Patricia Garvey

<[email protected]>; Louise Cullen <[email protected]>; Lisa

Domegan <[email protected]>; Francesco Maraglino

<[email protected]>; Antra Bormane <[email protected]>;

Dehler Silvia, Dr. med. <[email protected]>; Jurgita Pakalniškienė

<[email protected]>; greta.gargasiene

<[email protected]>; Jurgita Pakalniškienė

<[email protected]>; Jean-Claude Schmit <jean-

[email protected]>; Gauci Charmaine at Health Regulation

<[email protected]>; Hester de Melker <[email protected]>;

Susan van den Hof <[email protected]>; Macdonald, Emily Ann

<[email protected]>; Heidi Lange <[email protected]>; Zacharczuk

Katarzyna <[email protected]>; Mariana Ferreira

<[email protected]>; Pedro Licinio Pinto Leite

<[email protected]>; <[email protected]>; André Peralta

Santos <[email protected]>; Adriana Pistol

<[email protected]>; lucia.paulikova <[email protected]>; ecdc

<[email protected]>; maja.socan <[email protected]>; <[email protected]>;

Simón Soria. Fernando <[email protected]>;

<[email protected]>;

<[email protected]>; Agneta Falk Filipsson

<[email protected]>; Sara Bengtsson

<[email protected]>; birgitta.lesko

<[email protected]>; anette.richardson

<[email protected]>; DL_DPR_EVD

<[email protected]>

Teema: Draft public health guidance to support the assessment and

mitigation of the risk of locally acquired Aedes-borne viral diseases in

the EU/EEA - Stakeholder consultation

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu

saatja korral palume linke ja faile mitte avada.

To: National Focal Points, Emerging and Vector-borne Diseases Network

Cc: National Coordinators

Dear National Focal Points,

Due to the increasing number of locally acquired dengue cases in the past

years in some southern European countries, and the geographic spread of

invasive Aedes mosquito species in Europe, Aedes-borne viral diseases

pose an increasing public health threat in the EU/EEA. To support the

EU/EEA countries for surveillance, prevention and control of

autochthonous cases of Aedes-borne viral diseases (predominantly dengue

and chikungunya virus disease), ECDC has been working on the development

of a public health guidance to support the assessment and mitigation of

the risk of locally acquired Aedes-borne viral diseases in the EU/EEA.

As part of the guidance development, ECDC organised an expert workshop

between 16 and 18 April 2024 for consultation and active involvement of

national experts from four EU Member States which have had autochthonous

dengue and/or chikungunya cases in the past twelve years (i.e., France,

Italy, Spain and Portugal (Madeira)), as well as national experts from

three at-risk countries (Greece, Belgium and Germany). The invited

national experts have experience with the problems connected to

autochthonous transmissions of dengue and chikungunya or other mosquito-

borne viral disease outbreaks and the public health actions applied to

control the outbreaks. Additionally, laboratory / virology experts and

medical entomologists were invited to the workshop for topic-specific

contributions.

Based on the inputs collated during and after the meeting a draft

guidance was written, which we would like to share with you for

consultation (i.e. to review, comment and suggest modifications). Some

parts of the guidance are missing yet, which will be finalised in the

coming weeks, but the most relevant parts are ready for consultation.

The document is available at the ECON EVD NET site here:

Please put your comments into this document and use track changes in case

you implement any modifications in the text. Please do not upload

additional versions of the document with comments. Working on the same

document will allow you to see the comments of others (i.e., you do not

have to put the same comment if it was already put by someone else, and

you can further comment others comments).

The draft guidance will be discussed at the annual EVD-Net meeting on 12

November (i.e., three weeks from today). It would be great if you could

review and comment the document until the network meeting; however, it

will remain open for comments for an additional week after the meeting.

We plan to publish guidance by the end of 2024.

Should you not have access to the ECON site, please contact us by

answering to this email.

We are looking forward to your valuable comments and suggestions.

Best regards,

Tamás Bakonyi

on behalf of the EVD team

Confidentiality NoticeIf you are not the intended recipient of this

message, you are hereby kindly requested, to, consecutively, refrain from

disclosing its content to any third party, delete it and inform its

sender of the erroneous transmittal.

Classified as ECDC NORMAL